Identifiers
Database identifiers and provenance.
- Ligand ID
AWO- PDB
6itt- UniProt (similar protein)
P10721-4- Target protein
- P10721
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 124.3
- −1 ≤ LogP ≤ 5 5.62
- MW ≤ 500 Da 515.6
- LogP ≤ 5 5.62
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 124.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCc1cc(no1)NC(=O)Nc2ccc(cc2)c3cnc(s3)Nc4cc(ncn4)N5C=CN(C=C5)CCCCc1cc(no1)NC(=O)Nc2ccc(cc2)c3cnc(s3)Nc4cc(ncn4)N5C=CN(C=C5)CC
InChI=1S/C25H25N9O2S/c1-3-19-13-22(32-36-19)30-24(35)29-18-7-5-17(6-8-18)20-15-26-25(37-20)31-21-14-23(28-16-27-21)34-11-9-33(4-2)10-12-34/h5-16H,3-4H2,1-2H3,(H,26,27,28,31)(H2,29,30,32,35)InChI=1S/C25H25N9O2S/c1-3-19-13-22(32-36-19)30-24(35)29-18-7-5-17(6-8-18)20-15-26-25(37-20)31-21-14-23(28-16-27-21)34-11-9-33(4-2)10-12-34/h5-16H,3-4H2,1-2H3,(H,26,27,28,31)(H2,29,30,32,35)
UPVPVNFMFOJQIG-UHFFFAOYSA-NUPVPVNFMFOJQIG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- PDB
- Binding sites
- PF07714
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand AWO →
- PDB RCSB structure 6itt →
- UniProt UniProt P10721-4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “AWO”) →
Other ligands for this protein
Quick navigation to other ligands bound to P10721.
PDB 232
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).